| Dr Bruce Alfred St Amour Jr, DO | |
|
1900 Electric Rd, Salem, VA 24153-7494 | |
| (540) 776-4000 | |
| (540) 776-4196 |
| Full Name | Dr Bruce Alfred St Amour Jr |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1900 Electric Rd, Salem, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821030040 | NPI | - | NPPES |
| 114832768 | Medicaid | MI | |
| 114773193 | Medicaid | MI | |
| BS014898 | Other | MI | BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 014898 (Michigan) | Secondary |
| 207P00000X | Emergency Medicine | 0102205608 (Virginia) | Primary |
| Entity Name | Grinnell Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669420501 PECOS PAC ID: 0446153662 Enrollment ID: O20040127001219 |
News Archive
If Americans want a private health insurance system that does not base the price of individually sold policies on that individual's health status and that does not allow an insurer to refuse to sell a policy because of an individual's health issues, then they should accept a mandate that all Americans purchase at least a minimum package of health insurance (Uwe Reinhardt, 6/25).
Linagliptin phase III data were presented for the first time this week at the 70th Scientific Sessions of the American Diabetes Association (ADA), showing that this investigational compound, a dipeptidyl peptidase (DPP)-4 inhibitor, achieved significant, sustained and clinically meaningful reductions in blood glucose as measured by haemoglobin A1c (HbA1c), fasting plasma glucose (FPG), and postprandial glucose (PPG) concentrations.(1-6) Linagliptin is being investigated by Boehringer Ingelheim as a once-daily oral treatment in type 2 diabetes.
The key to balance is, in part, the ability to overpower your mind. Your brain possesses what some researchers call "common drive." It wants to activate and relax all muscles in synchrony, including the opposing ones.
KCI applauds the FDA for launching this important initiative to ensure that complex medical devices are used safely in the home by caregivers and patients. We have made it our priority and unwavering responsibility to help caregivers and patients understand how to use our advanced treatments safely. This includes offering a robust education and training program, employing highly trained clinical support staff and providing easy-to-read, patient-specific labeling.
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of innovative treatments for women's health and cancer, today announced that it had received the minutes from the U.S. Food and Drug Administration's (FDA) Clinical Guidance meeting that took place on November 8, 2010. In that meeting, the FDA agreed with the Company's proposed overall clinical development plan.
› Verified 3 days ago
| Entity Name | Des Moines River Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720472442 PECOS PAC ID: 0143549634 Enrollment ID: O20150505001794 |
News Archive
If Americans want a private health insurance system that does not base the price of individually sold policies on that individual's health status and that does not allow an insurer to refuse to sell a policy because of an individual's health issues, then they should accept a mandate that all Americans purchase at least a minimum package of health insurance (Uwe Reinhardt, 6/25).
Linagliptin phase III data were presented for the first time this week at the 70th Scientific Sessions of the American Diabetes Association (ADA), showing that this investigational compound, a dipeptidyl peptidase (DPP)-4 inhibitor, achieved significant, sustained and clinically meaningful reductions in blood glucose as measured by haemoglobin A1c (HbA1c), fasting plasma glucose (FPG), and postprandial glucose (PPG) concentrations.(1-6) Linagliptin is being investigated by Boehringer Ingelheim as a once-daily oral treatment in type 2 diabetes.
The key to balance is, in part, the ability to overpower your mind. Your brain possesses what some researchers call "common drive." It wants to activate and relax all muscles in synchrony, including the opposing ones.
KCI applauds the FDA for launching this important initiative to ensure that complex medical devices are used safely in the home by caregivers and patients. We have made it our priority and unwavering responsibility to help caregivers and patients understand how to use our advanced treatments safely. This includes offering a robust education and training program, employing highly trained clinical support staff and providing easy-to-read, patient-specific labeling.
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of innovative treatments for women's health and cancer, today announced that it had received the minutes from the U.S. Food and Drug Administration's (FDA) Clinical Guidance meeting that took place on November 8, 2010. In that meeting, the FDA agreed with the Company's proposed overall clinical development plan.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bruce Alfred St Amour Jr, DO 200 Corporate Blvd, Lafayette, LA 70508-3870 Ph: (800) 893-9698 | Dr Bruce Alfred St Amour Jr, DO 1900 Electric Rd, Salem, VA 24153-7494 Ph: (540) 776-4000 |
News Archive
If Americans want a private health insurance system that does not base the price of individually sold policies on that individual's health status and that does not allow an insurer to refuse to sell a policy because of an individual's health issues, then they should accept a mandate that all Americans purchase at least a minimum package of health insurance (Uwe Reinhardt, 6/25).
Linagliptin phase III data were presented for the first time this week at the 70th Scientific Sessions of the American Diabetes Association (ADA), showing that this investigational compound, a dipeptidyl peptidase (DPP)-4 inhibitor, achieved significant, sustained and clinically meaningful reductions in blood glucose as measured by haemoglobin A1c (HbA1c), fasting plasma glucose (FPG), and postprandial glucose (PPG) concentrations.(1-6) Linagliptin is being investigated by Boehringer Ingelheim as a once-daily oral treatment in type 2 diabetes.
The key to balance is, in part, the ability to overpower your mind. Your brain possesses what some researchers call "common drive." It wants to activate and relax all muscles in synchrony, including the opposing ones.
KCI applauds the FDA for launching this important initiative to ensure that complex medical devices are used safely in the home by caregivers and patients. We have made it our priority and unwavering responsibility to help caregivers and patients understand how to use our advanced treatments safely. This includes offering a robust education and training program, employing highly trained clinical support staff and providing easy-to-read, patient-specific labeling.
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of innovative treatments for women's health and cancer, today announced that it had received the minutes from the U.S. Food and Drug Administration's (FDA) Clinical Guidance meeting that took place on November 8, 2010. In that meeting, the FDA agreed with the Company's proposed overall clinical development plan.
› Verified 3 days ago
Mark E Todd, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1970 Roanoke Blvd, Salem, VA 24153 Phone: 540-982-2463 | |
Shane P Bossard, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1970 Roanoke Blvd, Salem, VA 24153 Phone: 540-982-2463 Fax: 540-983-1093 | |
Pratibha Joshi, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1970 Roanoke Blvd, Salem, VA 24153 Phone: 540-982-2463 Fax: 540-855-3475 | |
Dr. Sang Hyun Park, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1900 Electric Rd, Salem, VA 24153 Phone: 540-776-4000 | |
Dr. Lourdes Maria Page, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 429 Homeplace Dr, Salem, VA 24153 Phone: 540-529-6870 | |
Robert E Dowling, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1900 Electric Rd, Er Dept, Salem, VA 24153 Phone: 540-776-4970 | |
Dr. Adam Wali Hamidi, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1900 Electric Rd, Salem, VA 24153 Phone: 301-661-1145 |